COURTNEY STANDIFIRD: Open Payments
NPI 1023556578 · AVONDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$739 in 33 payments from 15 companies in 2025. Trend: 2023 $548 · 2024 $739 · 2025 $739
Food & beverage: $739
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 4 | $110 |
| GlaxoSmithKline, LLC. | 6 | $105 |
| Vanda Pharmaceuticals Inc. | 3 | $102 |
| AstraZeneca Pharmaceuticals LP | 4 | $64 |
| ABBVIE INC. | 3 | $50 |
| Dexcom, Inc. | 2 | $50 |
| MERZ NORTH AMERICA, INC. | 1 | $42 |
| Abbott Laboratories | 2 | $39 |
| ABIOMED | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 1 | $34 |
Products named: Korlym, TRELEGY ELLIPTA, FANAPT, Dexcom G6 Transmitter, AIRSUPRA, Xeomin, FREESTYLE LIBRE 3, LINZESS.
Industry payments across AZ — which companies pay providers there.
